These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 543741)

  • 1. Effects of theo-esberiven on the development of collateral circulation in dog hearts.
    Sakai K; Sakanashi M; Mizusawa H; Takenaka F; Takeshita S
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):104-14. PubMed ID: 543741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model.
    Lamping KA; Warltier DC; Hardman HF; Gross GJ
    J Pharmacol Exp Ther; 1984 May; 229(2):359-63. PubMed ID: 6232374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Theo-Esberiven on the coronary circulation and myocardial metabolisms in dogs (author's transl)].
    Sakai K; Mizusawa H; Sakanashi M; Sakamoto K; Takeo S; Takenaka F
    Nihon Yakurigaku Zasshi; 1978 Jan; 74(1):37-47. PubMed ID: 640535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic influences on the native canine coronary collateral circulation.
    Euler DE
    Cardiovasc Res; 1995 Jan; 29(1):33-7. PubMed ID: 7895236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global and regional haemodynamic effects of urapidil in conscious dogs with chronic coronary artery occlusion.
    Wouters PF; Marcus MA; Van Aken HK; van de Velde M; Miserez M; Deruyter HA; Mignolet K; Flameng W
    Eur J Anaesthesiol; 1994 Sep; 11(5):381-90. PubMed ID: 7988582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression and recovery of well-developed coronary collateral function in canine hearts after aorta-coronary bypass.
    Watanabe N; Yonekura S; Williams AG; Scheel KW; Downey HF
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):286-96. PubMed ID: 2492626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
    Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of neuroleptanalgesia agents on the collateral coronary circulation and systemic hemodynamics in acute myocardial ischemia].
    Iakushev MP; Sapozhkov AV
    Farmakol Toksikol; 1984; 47(4):59-62. PubMed ID: 6479313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isosorbide dinitrate ameliorates myocardial ischemia after development of collateral function in a canine model].
    Hisano K
    Fukuoka Igaku Zasshi; 1991 Sep; 82(9):480-91. PubMed ID: 1748370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isosorbide dinitrate ameliorates myocardial ischemia after development of collateral function in a canine model.
    Hisano K; Tomoike H; Inoue T; Mohri M; Nakamura M
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1289-96. PubMed ID: 2495354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An automated coronary artery occlusion device for stimulating collateral development in vivo.
    Rys R; LaDisa JF; Tessmer JP; Gu W; Kersten JR; Warltier DC; Pagel PS
    J Pharmacol Toxicol Methods; 2002; 48(2):111-8. PubMed ID: 14565568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the new specific bradycardia agent AQ-A39 (falipamil) on coronary collateral blood flow in dogs.
    Gross GJ; Daemmgen JW
    J Cardiovasc Pharmacol; 1987 Jul; 10(1):123-7. PubMed ID: 2441148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional development of the coronary collateral circulation during coronary artery occlusion in the conscious dog.
    Bloor CM; White FC
    Am J Pathol; 1972 Jun; 67(3):483-500. PubMed ID: 5033259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting effects of pharmacologic vasodilation on true collateral and overlap perfusion in ischemic myocardium.
    Keelan KE; Gross GJ; Brooks HL; Warltier DC
    Gen Pharmacol; 1984; 15(6):471-7. PubMed ID: 6526259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in coronary and collateral flows and adequacy of perfusion in the dog following one and three months of circumflex occlusion.
    Scheel KW; Galindez TA; Cook B; Rodriguez RJ; Ingram LA
    Circ Res; 1976 Nov; 39(5):654-8. PubMed ID: 975454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The septal artery and its collaterals in dogs with and without circumflex occlusion.
    Scheel KW; Wilson JL; Ingram LA; McGehee L
    Am J Physiol; 1980 Apr; 238(4):H504-14. PubMed ID: 7377321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclooxygenase blockade on blood flow through well-developed coronary collateral vessels.
    Altman J; Dulas D; Bache RJ
    Circ Res; 1992 Jun; 70(6):1091-8. PubMed ID: 1576731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protamine inhibits coronary collateral development in a canine model of repetitive coronary occlusion.
    Kersten JR; Pagel PS; Warltier DC
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H720-8. PubMed ID: 7532374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directional coronary collateral growth with chronic circumflex occlusion in the dog.
    Scheel KW; Rodriguez RJ; Ingram LA
    Circ Res; 1977 Apr; 40(4):384-90. PubMed ID: 844152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.